We are live on ! Find out more
GGHC

Gilder Gagnon Howe & Co Portfolio holdings

AUM $9.69B
1-Year Est. Return 55.7%
This Fund
S&P 500
This Quarter Est. Return
-5.21%
1 Year Est. Return
+55.7%
3 Year Est. Return
+243.5%
5 Year Est. Return
+259.56%
10 Year Est. Return
+4,571.41%
AUM
$6.31B
AUM Growth
-$1.31B
Cap. Flow
-$452M
Cap. Flow %
-7.17%
Top 10 Hldgs %
37.6%
Holding
304
New
27
Increased
63
Reduced
157
Closed
47

Top Buys

Rank Stock Value
1
TWOU
2U Inc
TWOU
+$75.8M
2
ADPT
Adeptus Health Inc
ADPT
+$73.7M
3
SHAK icon
Shake Shack
SHAK
+$53.8M
4
ULTA icon
Ulta Beauty
ULTA
+$45.2M
5
BWLD
Buffalo Wild Wings, Inc.
BWLD
+$43.1M

Top Sells

Rank Stock Value
1
AKAM icon
Akamai
AKAM
+$61.2M
2
TWTR
Twitter, Inc.
TWTR
+$55.8M
3
ESPR
Esperion Therapeutics
ESPR
+$51.1M
4
JD icon
JD.com
JD
+$50.8M
5
ZG icon
Zillow
ZG
+$45.8M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 21.45%
2 Healthcare 20.34%
3 Communication Services 17.82%
4 Technology 17.65%
5 Miscellaneous 10.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SIEN
226
DELISTED
Sientra, Inc.
SIEN
$161K ﹤0.01%
+1,588
New +$360K
ESPR
227
DELISTED
Esperion Therapeutics
ESPR
$134K ﹤0.01%
5,697
-814,008
-99% -$51.1M
SIRI icon
228
SiriusXM
SIRI
$9.9B
$122K ﹤0.01%
3,271
+88
+3% +$3.37K
FBIN icon
229
Fortune Brands Innovations
FBIN
$4.86B
$114K ﹤0.01%
2,799
+365
+15% +$15K
ENOV icon
230
Enovis
ENOV
$1.05B
$100K ﹤0.01%
1,938
+307
+19% +$20.4K
CVGW
231
DELISTED
Calavo Growers
CVGW
$98K ﹤0.01%
2,188
+20
+0.9% +$1.04K
SHW icon
232
Sherwin-Williams
SHW
$78.5B
$98K ﹤0.01%
1,320
-66,810
-98% -$5.86M
TCRT icon
233
Alaunos Therapeutics
TCRT
$3.84M
$95K ﹤0.01%
70
-163
-70% -$269K
PPLI
234
People Inc
PPLI
$2.79B
$94K ﹤0.01%
8,074
+84
+1% +$1.12K
MTG icon
235
MGIC Investment
MTG
$6.31B
$85K ﹤0.01%
9,148
– –
VMC icon
236
Vulcan Materials
VMC
$32.7B
$77K ﹤0.01%
866
+127
+17% +$11.8K
AXTA icon
237
Axalta
AXTA
$7.21B
$76K ﹤0.01%
3,017
-462,309
-99% -$13.7M
TMUS icon
238
T-Mobile US
TMUS
$196B
$67K ﹤0.01%
1,676
+8
+0.5% +$319
GNCA
239
DELISTED
Genocea Biosciences, Inc.
GNCA
$65K ﹤0.01%
1,184
– –
KMI icon
240
Kinder Morgan
KMI
$68.9B
$59K ﹤0.01%
2,117
– –
CCOI icon
241
Cogent Communications
CCOI
$478M
$42K ﹤0.01%
1,529
+19
+1% +$561
TIME
242
DELISTED
Time Inc.
TIME
$41K ﹤0.01%
2,175
-20
-0.9% -$423
DCOY
243
Decoy Therapeutics
DCOY
$1.78M
– –
0
– –
HRB icon
244
H&R Block
HRB
$5.56B
$33K ﹤0.01%
905
-147,117
-99% -$4.98M
IBRX icon
245
ImmunityBio
IBRX
$8.87B
$28K ﹤0.01%
+2,466
New +$53.8K
PEN icon
246
Penumbra
PEN
$12.5B
$27K ﹤0.01%
+666
New +$26.9K
BRK.B icon
247
Berkshire Hathaway Class B
BRK.B
$1.1T
$26K ﹤0.01%
200
– –
GRMN
248
Garmin
GRMN
$54.5B
$23K ﹤0.01%
635
-992,168
-100% -$39.5M
RNR icon
249
RenaissanceRe
RNR
$13.5B
$18K ﹤0.01%
167
– –
AAL icon
250
American Airlines Group
AAL
$8.67B
$17K ﹤0.01%
431
-1,005,332
-100% -$41.3M
8 9
10
11 12

Similar funds

Edgewood Management
Edgewood Management Greenwich, Connecticut $9.69B AUM 6.52% 1-Year Est. Return
SC
Starlite Capital Dallas, Texas $9.7B AUM
AV
ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return
FIA
Foundations Investment Advisors Phoenix, Arizona $9.72B AUM 29.41% 1-Year Est. Return
OAM
Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
PVI
Partners Value Investments Hamilton, Bermuda $9.8B AUM 0.07% 1-Year Est. Return
HTC
Hershey Trust Company Hershey, Pennsylvania $9.82B AUM 0.48% 1-Year Est. Return

Gilder Gagnon Howe & Co's Q3 2015 Portfolio in Review

As of Q3 2015, Gilder Gagnon Howe & Co held 304 positions worth $6.31B, down 17% from $7.61B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Gilder Gagnon Howe & Co withdrew a net $452M in Q3 2015, closing 47 positions and reducing 157 holdings. Its most notable exit was Silicon Laboratories, an estimated $28.1M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 21% of assets, up from 18% a quarter earlier, followed by Healthcare and Communication Services.

Against the trend, Gilder Gagnon Howe & Co opened a new position in Adeptus Health Inc worth $57.7M.

  • Gilder Gagnon Howe & Co's largest Q3 2015 buy was Adeptus Health Inc: 714,509 shares worth $57.7M.
  • Gilder Gagnon Howe & Co added most to 2U Inc in Q3 2015, an estimated $75.8M increase.
  • Gilder Gagnon Howe & Co's biggest Q3 2015 reduction was Akamai, cutting an estimated $61.2M.
  • Gilder Gagnon Howe & Co fully exited Silicon Laboratories in Q3 2015, selling an estimated $28.1M.
  • Gilder Gagnon Howe & Co's ten largest holdings make up 38% of its $6.31B portfolio in Q3 2015.
  • Gilder Gagnon Howe & Co opened 27 new positions and closed 47 in Q3 2015.
  • Gilder Gagnon Howe & Co's portfolio value fell 17% quarter-over-quarter to $6.31B.

Based on Gilder Gagnon Howe & Co's 13F filing for Q3 2015, filed 9 Nov 2015.